Advanced company searchLink opens in new window

SITRYX THERAPEUTICS LIMITED

Company number 10366466

Filter by category

Filter by category


Confirmation statement filters, selecting an input will reload the page.
Confirmation statement filters, selecting an input will reload the page.

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
16 Sep 2018 AP03 Appointment of Mrs Olivia Rosemary Kate Cavlan as a secretary on 31 August 2018
22 Jun 2018 SH01 Statement of capital following an allotment of shares on 1 June 2018
  • GBP 1,113.6307
12 Jun 2018 AA Total exemption full accounts made up to 31 December 2017
24 May 2018 AP01 Appointment of Andrew Neil Charles Weir as a director on 9 April 2018
01 May 2018 PSC07 Cessation of Houman Ashrafian as a person with significant control on 23 January 2018
21 Mar 2018 AP01 Appointment of Maina Bhaman as a director on 15 March 2018
21 Mar 2018 TM01 Termination of appointment of Henrijette Elsebeth Richter as a director on 15 March 2018
13 Feb 2018 AP01 Appointment of Paul-Peter Tak as a director on 23 January 2018
09 Feb 2018 TM01 Termination of appointment of Emma Tinsley as a director on 23 January 2018
09 Feb 2018 AP01 Appointment of Richard Aldrich as a director on 23 January 2018
09 Feb 2018 AP01 Appointment of Henrijette Elsebeth Richter as a director on 23 January 2018
08 Feb 2018 SH01 Statement of capital following an allotment of shares on 23 January 2018
  • GBP 8,586,447.01
07 Feb 2018 SH01 Statement of capital following an allotment of shares on 23 January 2018
  • GBP 240.01
07 Feb 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
05 Feb 2018 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
19 Jan 2018 AP03 Appointment of Miss Emma Tinsley as a secretary on 18 January 2018
09 Jan 2018 SH01 Statement of capital following an allotment of shares on 21 December 2017
  • GBP 200.01
09 Jan 2018 SH02 Sub-division of shares on 21 December 2017
05 Jan 2018 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Sub div 21/12/2017
14 Sep 2017 CS01 Confirmation statement made on 7 September 2017 with updates
14 Feb 2017 AP01 Appointment of Ms Catherine Elizabeth Bingham as a director on 1 February 2017
14 Feb 2017 AA01 Current accounting period extended from 30 September 2017 to 31 December 2017
08 Sep 2016 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2016-09-08
  • GBP .01